During critical healing stages, VersaWrap Hydrogel Sheet delivers a sustained gliding surface that reduces friction between opposing tissues and prevents postoperative tethering. VersaWrap Hydrogel Sheet fully bioresorbs throughout healing, leaving only the body’s natural tissues behind.
Ultrathin, sutureless, and non-swelling, VersaWrap Hydrogel Sheet is ready to use with no preparation required.
VersaWrap Hydrogel Sheet can be delivered as a conformable sheet or converted to a syringe-deliverable gel via the VersaWrap Application Kit, giving surgeons the flexibility to match the format to the anatomy and complexity of the case.
Learn how VersaWrap Hydrogel Sheet
helps patients move forward with confidence
Composition
VersaWrap Hydrogel Sheet is built on VersaCore Hydrogel Technology, the proprietary, naturally-derived biopolymer platform behind our soft-tissue protection portfolio. This bioresorbable composition provides a permeable, non-constricting gliding interface between target tissues and surrounding structures
Hyaluronic Acid (HA)
Hyaluronic Acid (HA)
- Known anti-inflammatory1
- Recruited to injury site, critical to healing1
- Immobilizes water on its surface, preventing cellular adhesion, facilitating gliding, movement, and debris removal
Alginate
Alginate
- Known to upregulate anti-inflammatory and downregulate inflammatory responses2
- Provides a hydrophilic matrix that gradually resorbs to locally expose embedded, bioavailable hyaluronic acid3
Engineered to Prevent Tethering
and Optimize Healing
Soft-tissue protection requires more than a physical barrier. VersaCore Hydrogel Technology combines distinct material properties that work together to prevent tethering, support natural healing, and leave only the body’s own tissues behind
Prevents Tethering
Prevents Tethering
- Provides protective gliding surface
- Negative charge naturally repels cellular attachment
Conformable
Conformable
- Conforms to tissue and implanted structures
- Ultrathin profile
- Non-swelling
- Non-constricting
Stays Where Applied
Stays Where Applied
- Mucoadhesive
- Sutureless
- Does not migrate
Selectively Permeable
Selectively Permeable
- Limits infiltration of proteins and cells
- Permits exchange of oxygen, nutrients, and small molecules (e.g., growth factors)
Bioresorbs Completely
Bioresorbs Completely
- Bioresorbs as part of the natural healing process
- Alternative to collagen-based materials that may remodel and add bulk
Biocompatible
Biocompatible
- No human or animal tissue
- Elicits little to no immune response
- Non-neurotoxic
- No tissue tracking requirements
Tissue Tracking NOT Required
Tissue Tracking NOT Required
- Suitable for patients with known cultural or physiological sensitivities to animal or human tissue products
Unparalleled Protection
One portfolio. Complete coverage. VersaWrap Hydrogel Sheet is cleared to protect tendons, ligaments, and skeletal muscles, and to manage peripheral nerves and the neural environment, across all age groups. VersaWrap Hydrogel Sheet may be placed adjacent to implants, hardware, and grafts, giving surgeons the confidence to protect every structure in the surgical field.
Tendon
Ligament
Muscle
Peripheral
Nerve
Nerve Root
Adjacent to Implants
Point-of-Care Configurable
VersaWrap Hydrogel Sheet offers on-demand flexibility as the only soft-tissue protection implant that can be applied as a conformable sheet or gel in a wet or dry field.
Sheet Application
Sheet Application
- No preparation needed
- Sutureless
- Continuous uniform coverage
- Planar and circumferential anatomy
Gel Application
Gel Application
- Syringe-deliverable gel
- Discrete aliquots
- Precise, controlled placement within complex or
difficult-to-access anatomical sites - Tight openings
- Minimally invasive approaches
| Part Number | Product Type | Size |
|---|---|---|
| VTP-1201 | VersaWrap Hydrogel Sheet | 1 x 2 inch (2.5 x 5 cm) |
| VTP-2201 | VersaWrap Hydrogel Sheet | 2 x 2 inch (5 x 5 cm) |
| VTP-2201A | VersaWrap Application Kit | 1 mL Wetting Solution |
** VersaWrap® Hydrogel Sheet is a single product regulated as VersaWrap® Tendon Protector and VersaWrap® Nerve Protector
References 1. Kawano Y, Patrulea V, Sublet E, Borchard G, Iyoda T, Kageyama R, and Hanawa T. (2021) Wound healing promotion by hyaluronic acid: Effect of molecular weight on gene expression and in vivo wound closure. Pharmaceuticals,14(4), 301. https://doi.org/10.3390/ph14040301;
2. Hirt N., et al. (2025). A novel calcium alginate hydrogel formulation to enhance monocyte/ macrophage anti-inflammatory activity. International Journal of Biological Macromolecules, 306. https://doi.org/10.1016/j.ijbiomac.2025.141251
3. Data on file, Alafair Biosciences
Always refer to the complete instructions for use for the complete clinical instructions.
This content is for informational purposes only and is not intended to constitute medical advice. As with any medical device, there are multiple factors affecting patient outcomes, including post-operative recovery time and activity level. Patient outcomes may vary based upon, among other factors, the nature and extent of loss or damage, the time between injury or damage and surgery, and the natural course of the patient’s recovery.
The availability of these products is in the United States only. Warning: Applicable laws restrict these products to sale by or on the order of a physician.